Global patent index - EP 1007687 A1

EP 1007687 A1 2000-06-14 - FIV VACCINE

Title (en)

FIV VACCINE

Title (de)

FIV IMPFSTOFF

Title (fr)

VACCIN ANTI-VIF

Publication

EP 1007687 A1 (EN)

Application

EP 98912585 A

Priority

  • GB 9800715 W
  • GB 9704977 A

Abstract (en)

[origin: WO9840493A1] Vaccine formulations for FIV related disease comprising a FIPV polynucleotide comprising a dysfunctional pol gene, FIPV polynucleotide fragments, and uses therefor in the prophylaxis and/or treatment of FIV-related disease.

IPC 1-7 (main, further and additional classification)

C12N 15/49; A61K 31/70; A61K 48/00

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 31/7105 (2006.01); A61K 38/21 (2006.01); A61K 39/21 (2006.01); A61K 48/00 (2006.01); A61P 31/14 (2006.01); C07K 14/155 (2006.01); C12N 5/10 (2006.01); C12N 15/49 (2006.01)

CPC (invention and additional information)

C07K 14/005 (2013.01); A61K 2039/51 (2013.01); C12N 2740/15022 (2013.01)

Citation (search report)

See references of WO 9840493A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9840493 A1 19980917; AU 6736998 A 19980929; CA 2283490 A1 19980917; EP 1007687 A1 20000614; GB 9704977 D0 19970430; JP 2002501369 A 20020115

INPADOC legal status

2005-01-12 [18W] WITHDRAWN

- Ref Legal Event Code: 18W

- Effective date: 20041112

2003-09-10 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20030725

2000-06-14 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 19990827

2000-06-14 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE